The Journal of Neuroscience, September 3, 2003, 23(22):8176-8184
Previous Article
Slit2 Guides Both Precrossing and Postcrossing Callosal Axons at the Midline In Vivo
Tianzhi Shu,1
Vasi Sundaresan,4
Margaret M. McCarthy,2,3 and
Linda J. Richards1,3
Departments of 1Anatomy and Neurobiology and
2Physiology and 3Program in
Neuroscience, The University of Maryland, Baltimore, School of Medicine,
Baltimore, Maryland 21201, and 4Department of
Histopathology, St. Thomas' Hospital, London SE1 7EH, United Kingdom
 |
Abstract
|
|---|
Commissural axons generally cross the midline only once. In the
Drosophila nerve cord and mouse spinal cord, commissural axons are
guided by Slit only after they cross the midline, where Slit prevents these
axons from recrossing the midline. In the developing corpus callosum, Slit2
expressed by the glial wedge guides callosal axons before they cross the
midline, as they approach the corticoseptal boundary. These data highlighted a
potential difference between the role of Slit2 in guiding commissural axons in
the brain compared with the spinal cord. Here, we investigate whether Slit2
also guides callosal axons after they cross the midline. Because such
questions cannot be addressed in conventional gene knock-out animals, we used
in utero injections of antisense oligonucleotides to specifically
deplete Slit2 on only one side of the brain. We used this technique together
with a novel in vitro assay of hemisected brain slices to
specifically analyze postcrossing callosal axons. We find that in the brain,
unlike the spinal cord, Slit2 mediates both precrossing and postcrossing
axonal guidance. Depletion of Slit2 on one side of the brain causes axons to
defasciculate and, in some cases, to aberrantly enter the septum. Because
these axons do not recross the midline, we conclude that the principle
function of Slit2 at the cortical midline may be to channel the axons along
the correct path and possibly repel them away from the midline. We find no
evidence that Slit2 prevents axons from recrossing the midline in the
brain.
Key words: corpus callosum; commissure; axon guidance; cortical development; glial wedge; midline; Slit; Robo; antisense oligonucleotides
 |
Introduction
|
|---|
Commissural axons comprising the corpus callosum connect neurons in the
right and left cortical hemispheres. During development, callosal axons
arising principally from neurons in layers 2/3 and 5 project initially to the
intermediate zone, probably under the influence of class 3 semaphorins
(Polleux et al., 1998
).
Callosal axons grow medially and ventrally to reach the corticoseptal
boundary, at which they encounter a bilaterally symmetrical structure called
the glial wedge (Shu and Richards,
2001
), and turn sharply to cross the midline. After crossing the
midline, callosal axons encounter the contralateral glial wedge and make
another turn dorsally to enter the intermediate zone of the contralateral
cingulate cortex. These striking morphological changes in the direction of
callosal axon trajectories in vivo suggest that these axons are being
guided by molecules within the local environment. Additional evidence of this
is the large number of genetic mutations that result in agenesis of the corpus
callosum (for review, see Richards,
2002
) and cause a similar acallosal phenotype. In most cases,
axons are able to reach the midline but are unable to cross, continuously
growing into large swirls of axons known as Probst bundles. This phenotype is
apparent whether the gene mutation affects callosal axons intrinsically
(Shen et al., 2002
) or whether
the mutation effects the development of midline structures
(Shu et al., 2003
) or the
molecules they express (Bagri et al.,
2002
).
Midline glial structures have been shown to regulate commissural axon
guidance in a number of systems (Van
Hartesveldt et al., 1986
;
Jacobs and Goodman, 1989
;
Mori et al., 1990
;
Snow et al., 1990
;
Marcus et al., 1995
;
Cummings et al., 1997
;
Pires-Neto et al., 1998
;
Wu et al., 1998
). Work in
invertebrates and in the vertebrate spinal cord has begun to elucidate some of
the molecules involved in midline glial directed guidance. One of these
molecules, Slit2, and its Robo receptors were first identified in
Drosophila and then subsequently cloned in mammals (Kidd et al.,
1998
,
1999
;
Brose et al., 1999
;
Li et al., 1999
;
Wang et al., 1999
). In
Drosophila, and at the rodent cortical midline, Slit2 is expressed by
midline glia (Kidd et al.,
1999
; Nuygen-Ba Charvet et al., 1999;
Shu and Richards, 2001
). In
Slit2 knock-out mice, callosal axons form Probst bundles, and laterally
projecting axons form ectopic commissures and project aberrantly into ventral
regions of the basal telencephalon (Bagri
et al., 2002
). These results suggest a role for Slit2 in guiding
cortical axons as they approach the midline before they cross.
In vitro "open book" assays of the developing spinal
cord show that Slit2 and class 3 semaphorins regulate commissural axon
guidance only after the axons cross the midline
(Zou et al., 2000
), although
this has not been demonstrated in vivo. Here, we investigate whether
in the brain Slit2 regulates axonal guidance both before and after callosal
axons cross the midline. These results demonstrate a significant difference
between how this molecule regulates the development of commissures in the
spinal cord and brain.
 |
Materials and Methods
|
|---|
Animals and perfusion. Embryos used in this study were obtained
from timed pregnant C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME).
Females were checked for the presence of a vaginal plug after overnight mating
with a male [designated as embryonic day 0 (E0) for the purpose of staging the
embryos]. On the required gestational day, pregnant dams were anesthetized
with Nembutal (0.07 mg/gm body weight; Henry Schein, Melville, NY) until they
attained a deep state of anesthesia. The mother's abdominal cavity was opened,
and the embryos were removed and perfused with 0.9% saline, followed by 4%
paraformaldehyde (ICN, Irvine, CA), as described previously
(Shu et al., 2000
). Once all
of the embryos had been removed, the mother was given a lethal dose of
Nembutal (0.1 mg/gm).
Coculture assays. E17 embryos were removed from anesthetized dams
as described above. Brains were dissected and sectioned coronally on a
vibratome. Cortical explants, bisected slices, and glial wedge explants were
dissected in L-15 growth medium (Invitrogen, Gaithersburg, MD). Cortical
explants or hemisected slices were cocultured with either another cortical
explant or a glial wedge explant in collagen gels with DMEM/F-12 medium
(Invitrogen), 1% penicillin-streptomycin, 0.28% glucose, 1% of 200
mM glutamine, 5% rat serum, and 10% FBS (Invitrogen, San Diego,
CA), as described previously (Shu et al.,
2001
). After3din culture, explants were fixed overnight with 4%
paraformaldehyde, and 10% DiI was injected into the explants to label axon
outgrowth. Sytox Green (Molecular Probes, Eugene, OR) was used as a
counterstain. Cultures were analyzed by confocal microscopy (Fluoview; Olympus
Immunochemicals, Lake Success, NY). The number and length of axons on the
proximal and other sides of the explants were measured and compared using
two-way ANOVA, followed by post hoc analysis with Newman-Keuls test
and paired t tests.
Synthesis of Robo1 and Robo2 ectodomain proteins. In some
experiments, Robo1 and Robo2 ectodomain proteins were added to the culture
medium. An in vitro transcription and translation system (TNT
T7-coupled reticulocyte lysate system, l4611; Promega, Madison, WI) was used
to directly produce the proteins from Robo DNA constructs. The constructs were
made by inserting a sequence of the Robo1 or Robo2 ectodomain fused with a
human Fc fragment into the PsectagB plasmid (a gift from Dr. M.
Tessier-Lavigne, Stanford University, Stanford, CA), as described previously
(Stein and Tessier-Lavigne,
2001
).
Immunohistochemistry and in situ hybridization. For
Robo1/2 and 3A10 immunocytochemistry, 5 µm paraffin sections were dewaxed,
then treated with 0.3% hydrogen peroxidase in distilled water for 5 min. After
blocking in 2% BSA in TBS for 10 min at room temperature, antibodies Robo1/2
(see below) or 3A10 (Developmental Studies Hybridoma Bank, Iowa City, IA)
(Serafini et al., 1996
) were
applied overnight at dilutions of either 1:2000 or 1:20 of neat supernatant.
Slides were washed in TBS and exposed to a biotinylated swine anti-rabbit and
goat anti-mouse antibody (1:200 dilution; Dako, Carpinteria, CA),
respectively, for 1 hr at room temperature. Slides were then washed in TBS and
incubated with the streptavidin, biotin, and peroxidase complex (Strept ABC
complex/HRP; 1:100 dilution; Dako) for 1 hr at room temperature. After three
washes for 5 min, slides were incubated with a Tyramide solution (1:150
dilution; NEN, Boston, MA) for 5 min at room temperature and then washed three
times before incubating with the ABC complex for another 30 min. The
chromogenic substrate of peroxidase was a solution of 0.05%
3,3'-diaminobenzidine tetrahydrochloride and 0.03%
H2O2 in 0.05 mol/l TBS, pH 7.5. The slides were
counterstained with Harris' hematoxylin. Normal rabbit preimmune serum was
used as a negative control. Positive immunoreactivity was also competed out by
the peptide immunogen.
Robo1/2 antibody. The Robo1/2 rabbit polyclonal antibody was
raised against a synthetic peptide corresponding to a 19 amino acid sequence
located in the first Ig domain of Robo1 (RLRQEDFPPRIVEHPSDLI) [Quality
Controlled Biochemicals (QBC), Hopkinton, MA]
(Hivert et al., 2002
). The
antibody was affinity purified (QCB) and stored as a stock solution at 1
µg/µl.
For GFAP immunohistochemistry, 50 µm vibratome sections were labeled
free-floating. Sections were blocked in a solution consisting of 2% (v/v)
donkey serum in PBS for 2 hr and then washed in PBS. A rabbit anti-GFAP
antibody (1:1000; Dako) was placed on the sections overnight to label the
glial wedge. In different experiments, either Cy2- or Cy5-conjugated donkey
anti-rabbit secondary antibodies (1:500; Jackson ImmunoResearch Laboratories,
West Grove, PA) were used. Cy2 labeling was visualized as green, and Cy5
labeling was visualized as blue by confocal microscopy.
Slit2 in situ hybridization was performed on 10 µm cryostat
sections as described previously (Shu et
al., 2001
).
In utero injection of oligonucleotides. Slit2 antisense
oligonucleotides with the sequence 5'-CAGCCAATGCCACTCATCTT-3' and
a control sequence of 5'-CCGCCACTTCATACATCATT-3' were produced
commercially (Oligos, Etc., Ridgefield, CT). Antisense oligonucleotides were
designed with the following criteria: (1) to span the translation start codon
to inhibit the translation of SLIT2 protein; (2) to contain a roughly
equivalent percentage of AT versus GC residues, critical for maintaining a
stable structure; (3) not to contain any stable secondary structures, and not
to form homodimers; and (4) to ensure that the antisense oligonucleotide was
specific for Slit2, a BLAST search of GenBank of the sequence was performed. A
sense triplet of the start codon was synthesized within the control
oligonucleotide, and a BLAST search of GenBank was also performed on the
control oligonucleotide to ensure that it did not bind other known genes in
the database. Oligonucleotides contained limited phosphothioate linkages to
increase resistance to nuclease degradation
(Szklarczyk and Kaczmarek,
1995
). Some oligonucleotides were tagged with fluorescein at both
3' and 5' ends to allow the detection of the oligonucleotides
after the injection. The oligonucleotides were reconstituted in sterilized
water at a concentration of 2 µg/µl and stored at -70°C. A dosage of
0.5 µl of each of the oligonucleotides was injected into the lateral
ventricle of each embryo. Timed pregnant mice at either E15 or E16 were used
for the in utero injections. Mice were anesthetized with sodium
pentobarbital (Nembutal) at 0.07 mg/gm body weight (diluted in 50%
MgSO4 in saline) and then placed on a warming pad to maintain their
body temperature. Once deeply anesthetized, the mother's abdomen was opened to
expose the uterus under a dissection microscope. A pulled glass pipette
attached to a Picospritzer (General Valve, Fairfield, NJ) was manually
inserted into the lateral ventricle through the uterine wall. In the same dam,
embryos in one uterine horn were injected with Slit2 antisense
oligonucleotides, and embryos in the other uterine horn were injected with
control oligonucleotides. After the injection, the mothers' abdomen was
sutured closed, and the animal was allowed to recover. After 1 or 2 d
survival, the embryos were perfused (on E17) with 0.9% saline, followed by 4%
paraformaldehyde. DiI or DiA was injected into the medial cortex of fixed
brains to label the precrossing or the postcrossing callosal axons. Brains
were stored in 4% paraformaldehyde in light-proof vials at room temperature
for 4 weeks to allow time for the diffusion of the dyes in the fixed brains.
Brains were then sectioned on a vibratome into 50-µm-thick sections and
labeled for GFAP immunohistochemistry, as described above. Sections were then
analyzed by confocal microscopy (Olympus Immunochemicals). DiI and Cy5
labeling were excited with a krypton laser (568 nm emission), and DiA was
excited with an argon laser (488 nm emission). Each fluorophore was imaged by
single-laser illumination of the sample using barrier filters (Chroma, San
Antonio, TX). Each image was scanned two or three times, once for each
fluorophore, and then the images were superimposed in Photoshop (Adobe) using
a Macintosh G3 computer.
 |
Results
|
|---|
Glial wedge-mediated repulsion-suppression of cortical axon growth
in vitro can be blocked by the addition of Robo1 and Robo2 ectodomain
proteins
In vitro, glial wedge explants can suppress and repel the growth
of cortical axons, and in organotypic slice cultures, reorientation of the
glial wedge causes axon misrouting (Shu
and Richards, 2001
). This glial wedge activity can be mimicked by
Slit2-expressing cell blocks in vitro. Therefore, because Slit2 is
expressed by glial wedge cells in vivo, these data suggested that the
repulsive-suppressive guidance activity of the glial wedge may be caused by
Slit2.
To further investigate this, we performed function blocking experiments by
adding soluble Robo1 and Robo2 ectodomain proteins to collagen gel cocultures
of cortex and glial wedge. Both Robo1 and Robo2 bind Slit2 with high affinity,
and both are expressed in cortical neurons; therefore, if the activity is
caused by Slit2, the addition of Robo1/2 ectodomain proteins should bind to
Slit2 expressed by the glial wedge and diminish the repulsive-suppressive
activity. Robo1 and Robo2 ectodomain proteins translated in vitro had
an expected molecular weight of 150-160 kDa
(Fig. 1A). As
described previously, in cortex-cortex explant cocultures (n = 11),
axons grew into the apposing cortical explant
(Fig. 1B). However,
when cortex was cultured with glial wedge (n = 11), significantly
fewer axons grew into the glial wedge explant
(Fig. 1C,F; 1.6 vs
15.6 axons; p < 0.01; post hoc analysis with Newman-Keuls
test). Axons growing on the side proximal to the glial wedge were also
significantly shorter compared with either axons growing on the other three
sides of the explant in the same culture (164.7 µm vs 228.5 µm; paired
t test; p < 0.05; Fig.
1C,F) or compared with axons growing in cortex-cortex
cocultures on the proximal side (mean length, 285.9 µm) or the other three
sides (mean length, 263.8 µm; Fig.
1B,F). In cultures in which the Robo1/2 ectodomain
proteins were added, the respulsive-suppressive activity of the glial wedge
could be blocked in a titratable manner. In these cultures, significantly more
axons grew into the glial wedge explant (for 2 ng/µl: 6.4 vs 1.6 axons;
p < 0.05; for 20 ng/µl: 10 vs 1.6 axons; p < 0.01;
post hoc analysis with Newman-Keuls test). Furthermore, axons facing
the glial wedge grew to control lengths in the presence of either 2 ng/µl
(255.0 µm vs 266.1 µm) or 20 ng/µl (256.7 µm vs 226.4 µm) of
Robo ectodomain proteins.

View larger version (74K):
[in this window]
[in a new window]
|
Figure 1. Robo ectodomain proteins block the chemosuppressive-repulsive effect of the
glial wedge. Robo1 and Robo2 ectodomain proteins were synthesized using an
in vitro transcription-translation system and visualized by Western
blot analysis by the incorporation of biotinylated lysines (A). Both
Robo1 and Robo2 ectodomain proteins were produced with an estimated mass of
150-160 kDa (A, lanes 2 and 3), consistent with previous findings
(Brose et al., 1999 ). In the
control lane (A, lane 1), an empty vector was added to the reaction,
and, thus, no protein was produced. Collagen gel experiments were performed
using explants derived from E17 brain slices. Cortical explants (Ctx) were
cocultured with glial wedge (GW) explants (C) or another cortical
explant (B) as controls. As described previously, the GW causes a
growth suppression-repulsion of cortical axons (B). Robo ectodomain
proteins were mixed and added to the growth medium of Ctx/GW cocultures at
either 2 ng/µl total protein (D) or 20 ng/µl total protein
(E). After 3 d in culture, explants were fixed, and DiI was injected
into the cortical explant to label the axons. F, G, Significantly
more, and longer, axons grew into the GW when either 2 ng/µl or 20 ng/µl
of the Robo ectodomain proteins was added to the cultures
(*p < 0.05; ANOVA), indicating the inhibitory effect of
the GW had been blocked. Histograms represent the mean ± SEM. Scale bar
(in E): B-E, 150 µm.
|
|
These data suggest that in vitro the repulsive-suppressive
activity (or a major component of it) expressed by the glial wedge binds to
Robo ectodomain proteins and is, therefore, likely to be Slit2.
Callosal axons express Robo receptors
We previously showed that both Robo1 and Robo2 were expressed in the
cortical plate at E17, a time when the corpus callosum is forming
(Shu and Richards, 2001
).
However, because this experiment was performed by in situ
hybridization, we could not be sure that these receptors were expressed on
callosal axons. Using a pan Robo1 and Robo2 antibody, we find that callosal
axons express these receptors at high levels at E15-E17
(Fig. 2), a time when callosal
axons are actively pathfinding. Robo antibodies labeled callosal axons as they
approached the midline at E15 (Fig.
2A,B, arrow) and crossed at E16
(Fig. 2C,D, arrow). At
E17, Robo immunostaining of the corpus callosum overlapped with 3A10
immunolabeling, which labels neurofilaments
(Fig. 2E,F, arrow).
The lateral cortical projection through the internal capsule was also labeled
by the Robo antibody (Fig.
2C, arrow). This expression, along with phenotypes
observed in the Slit2 knockout mouse (Bagri
et al., 2002
), suggests that in vivo callosal and
laterally projecting cortical axons are guided by Slit2 through Robo
receptors.

View larger version (176K):
[in this window]
[in a new window]
|
Figure 2. Callosal axons express Robo receptors. Robo immunohistochemistry-labeled
callosal axons at E15 (A, B, arrow; B is a higher-power view
of the region delineated in A), as axons approach the midline and as
they cross at E16 (C, D, arrow; D is a higher-power view of
the region delineated in C). Robo labeling at E17 (F)
overlaps with 3A10 antibody labeling in an adjacent section (E, F,
arrows). The lateral cortical projection through the internal capsule is also
labeled by the Robo antibodies (C, arrow). All panels are of coronal
sections. Scale bar (in F): A, C, 700 µm; B, 180
µm; D-F, 200 µm.
|
|
Slit2 antisense oligonucleotides bind to regions of Slit2 expression
in vivo
To investigate the role of Slit2 in guiding callosal axons at the midline
in vivo, we generated Slit2 antisense oligonucleotides and injected
them into the lateral ventricle of mouse embryonic brains in utero.
Slit2 antisense and control oligonucleotides
(Fig. 3A) were
injected into brains using a pulled glass micropipette attached to a
picospritzer. A small amount of fast green dye, used for visualization during
the injection procedure, indicated that injections were largely confined to a
single cortical hemisphere (Fig.
3B, arrow). Oligonucleotides were end-labeled with
fluorescein, so that they could be visualized after sectioning to determine
their distribution. In all cases analyzed (n = 6), Slit2
oligonucleotides localized to the corticoseptal boundary
(Fig. 3C,D), a region
of high Slit2 expression (Fig.
3E,F). Colabeling with an anti-GFAP antibody
(Fig. 3C,D, red
labeling) indicated that Slit2 oligonucleotides
(Fig. 3C,D, green
labeling) were present in glial wedge cells. Control oligonucleotides were
also present in the glial wedge but tended to be more widely distributed at
the corticoseptal boundary (see Fig.
5F). One possible explanation for this wider distribution
is that the control oligonucleotides did not bind to specific mRNAs within the
cells. Therefore, Slit2 oligonucleotides preferentially bind to regions of
Slit2 expression, enabling them to cause a downregulation of Slit2 protein
expression, as has been described previously for this technique
(Toulme, 1997
). Labeled
oligonucleotides were only observed in brains after 24 hr and were no longer
observed at 48 hr. This probably reflects a degradation of the
oligonucleotides by 48 hr, making this technique very precise for regulating
protein expression on a single developmental day.

View larger version (98K):
[in this window]
[in a new window]
|
Figure 3. Slit2 antisense oligonucleotides are localized in glial wedge cells after
in utero injection. Sequences of the Slit2 and control antisense
oligonucleotides used are shown in A. The binding region of the Slit2
antisense is indicated by the alignment (A). Slit2 antisense
oligonucleotides were mixed with a small amount of fast green dye to visualize
the injection site. The dye remained within the injected hemisphere
(B; arrow indicates the injection site). In this case, the injection
was performed at E16 and is visualized after perfusion on E17. To localize the
Slit2 antisense oligonucleotides, fluorescein-tagged Slit2 antisense
oligonucleotides were injected at E16, and brains were perfused after 24 hr
and labeled with GFAP immunohistochemistry. Slit2 antisense oligonucleotides
(C, D, green dots) were present in the glial wedge, which was
identified by GFAP immunohistochemistry (C, D, red processes). Slit2
antisense oligonucleotides were located in the ventricular and subventricular
zones of the corticoseptal boundary within the soma of the glial wedge cells
(D is a higher-power view of the region delineated in C).
This distribution resembled the expression pattern of Slit2 mRNA by in
situ hybridization (F is a higher-power view of the boxed region
in E). B is a dorsal view, and C-F are coronal
sections. Scale bar (in F): B, 6 mm; C, 400 µm;
E, 200 µm; D, F, 50 µm.
|
|

View larger version (105K):
[in this window]
[in a new window]
|
Figure 5. Pathfinding errors of callosal axons in brains injected with Slit2
antisense oligonucleotides at E16. E16 brains injected with control
oligonucleotides displayed normal callosal pathfinding (A, B, F,
DiI-labeled red axons; B is a higher-power view of the region
delineated in A). However, brains injected with Slit2 antisense
oligonucleotides displayed varying degrees of pathfinding errors (C-E,
G, DiI-labeled red axons). In some brains, axons deviated from the main
bundle (C, arrow), and in others the majority of axons grew
aberrantly into the septum (D, E, G, arrows). Some experiments were
performed with fluorescein-tagged control (F) or Slit2 antisense
(G) oligonucleotides and could be detected at the cortiocseptal
boundary and within the glial wedge (F, G, green dots). All sections
are in the coronal plane and represent different brains in each panel, except
in A and B. The glial wedge is labeled with GFAP
immunohistochemistry in green in A-E and in pseudo-blue in F
and G. Scale bar (in G): A, 400 µm; B,
D, 150 µm; C,E-G, 200 µm.
|
|
Slit2 antisense oligonucleotides cause aberrant callosal axon
pathfinding of precrossing axons
Because the first callosal axons cross the midline at E15.5
(Rash and Richards, 2001
),
Slit2 antisense oligonucleotides were injected into a single lateral ventricle
of the brains of either E15 (Fig.
4) or E16 (Fig. 5)
mouse pups in utero. All embryos were then perfused at E17, injected
with DiI, and later processed for GFAP immunohistochemistry. In brains
injected with control antisense oligonucleotides (n = 6 at E15 and
n = 11 at E16), callosal axons crossed the midline and grew dorsally
into the opposite hemisphere (Figs.
4A,C,
5A,B,F, red axons). In
Slit2 antisense oligonucleotide-injected brains at E15 (n = 5 of 6),
large numbers of callosal axons either deviated from the main bundle
(Fig. 4D) or failed to
cross the midline completely, beginning to form Probst-like bundles
(Fig. 4B, asterisk) or
growing aberrantly into the septum (Fig.
4B, arrowhead; Table
1). Even after only a 24 hr survival period, we observed dramatic
errors in callosal axon pathfinding in the presence of the Slit2 antisense
oligonucleotides (n = 12 of 13 displayed pathfinding errors). The
phenotypes varied from subtle deviations from the main bundle
(Fig. 5C) to more
severe phenotypes, where the majority of axons failed to cross the midline and
grew into the septum (Fig.
5D,E; Table
1). In brains injected with FITC end-labeled oligonucleotides,
both Slit2 and control antisense oligonucleotides were present at the
corticoseptal boundary (Fig.
5F,G, green dots), but only brains injected with Slit2
antisense oligonucleotides displayed axonal pathfinding errors
(Fig. 5G) compared
with controls (Fig.
5F, Table
1). The more severe cases resembled the phenotype observed in
Slit2 knock-out mice (Bagri et al.,
2002
), indicating that the variability observed was probably
because of variations in the amount of Slit protein "knockdown"
achieved between brains.

View larger version (115K):
[in this window]
[in a new window]
|
Figure 4. In utero injection of Slit2 antisense oligonucleotides disrupts
precrossing callosal axon pathfinding at midline on E15. Control (A,
C) or Slit2 antisense (B, D) oligonucleotides were injected into
the right lateral ventricle of E15 mouse embryos. On E17, the injected embryos
were perfused, and after postfixation, DiI was injected into the medial cortex
to label callosal axons (axons labeled red in all panels). GFAP
immunohistochemistry was used to label the glial wedge (GW) (A, B,
green labeling; C, D, pseudo-blue labeling). Control
oligonucleotide-injected brains developed a normal corpus callosum (CC)
(A, C; two different brains). Brains injected with Slit2 antisense
oligonucleotides displayed dramatic axon pathfinding errors at the midline.
Many callosal axons stalled at the midline and failed to cross, sometimes
forming Probst bundle-like structures (B, asterisk). Some axons
projected aberrantly into the septum (B, arrow). Unlabeled
oligonucleotides were used in A and B, and
fluorescein-labeled oligonucleotides were used in C and D;
however, the fluorescein tag could not be detected after the 2 d survival
period (C, D). All sections are in the coronal plane. Scale bar (in
D): A, 300 µm; B, 250 µm; C, D, 150
µm.
|
|
Postcrossing callosal axons are guided by Slit2 and the glial
wedge
The glial wedge is a bilaterally symmetrical structure, present on either
side of the midline at the corticoseptal boundary
(Shu and Richards, 2001
). To
investigate the role of Slit2 and the glial wedge in regulating the growth
trajectories of callosal axons after they cross the midline, we injected
control or Slit2 antisense oligonucleotides into brains and then
simultaneously analyzed both precrossing and postcrossing axons.
Oligonucleotides were injected on E16, and brains were perfused on E17 and
injected with DiA in the same hemisphere to label precrossing axons and with
DiI in the opposite hemisphere to label postcrossing axons
(Fig. 6A).

View larger version (99K):
[in this window]
[in a new window]
|
Figure 6. Disruption of postcrossing callosal axons in vivo by Slit2
antisense oligonucleotides. To investigate the role of Slit2 in regulating the
growth of postcrossing callosal axons, we injected either control
oligonucleotides (B, C) or Slit2 antisense oligonucleotides
(D-H) into the right lateral ventricle of E16 embryos in
utero. Embryos were perfused on E17 and later labeled with either DiA to
label the precrossing axons (green axons in all panels) or DiI to label the
postcrossing axons (red axons in all panels). A schematic of the experimental
paradigm is shown (A). The glial wedge was labeled with GFAP and a
Cy5 secondary antibody (blue labeling in all panels). In control
oligonucleotide-injected brains (C is a higher-power view of the
region delineated in B), both precrossing and postcrossing callosal
axons crossed the midline normally and overlapped within the same tract
(B, C; yellow labeling indicates overlapping axons). In brains
injected with Slit2 antisense oligonucleotides, both precrossing and
postcrossing callosal axons displayed pathfinding errors (D-H).
Aberrant pathfinding of precrossing axons was observed (E, F, H,
arrowheads; E is a higher-power view of the region delineated in
D; F is another section from the same brain) as shown in
Figure 5 and served as an
internal control for the knockdown of Slit2. Postcrossing axons also displayed
pathfinding errors. Axons left the main callosal bundle, grew into the septum
or even ventrally along the midline (E-G, axons labeled with an
arrow). In some cases, axons did not even cross the midline or formed
Probst-like bundles (H, red axons and bundle labeled by an asterisk;
G and H are examples from two additional brains). All
sections are in the coronal plane. Fluorescein-labeled oligonucleotides were
used in B, C, G, and H (green dots in these panels;
H, small arrow); unlabeled oligonucleotides were used in
D-F. Scale bar (in H): B, D, 200 µm; C,
E-H, 100 µm.
|
|
In control-injected brains (n = 8), callosal axons from both
hemispheres crossed the midline and overlapped within the tract of the corpus
callosum (Fig. 6B,C).
No axons from either hemisphere were observed deviating from the main bundle.
In Slit2 antisense oligonucleotide-injected brains, precrossing callosal axons
were again observed deviating from the main bundle and growing into the septum
(Fig. 6D-H, green
axons, E,F,H, arrowheads; n = 7 of 9 displayed pathfinding
errors; Table 1). In this
experiment, axons from the contralateral hemisphere that had already
encountered endogenous levels of Slit2 protein expressed in the untreated
hemisphere encountered presumably lower levels of Slit2 protein once they
crossed the midline. In 100% of cases in which the precrossing axons displayed
pathfinding errors (n = 7 of 7;
Table 1), postcrossing axons
were also observed growing aberrantly into the contralateral septum
(Fig. 6E,F, red axons
labeled with arrows) or deviating from the main bundle
(Fig. 6G,H, arrows).
In more severe cases, some axons from the contralateral hemisphere did not
cross the midline and began to form Probst-like bundles
(Fig. 6H, red axons
labeled by an asterisk).
These results indicated that Slit2 expressed by the glial wedge was
required for maintaining axons within the main callosal bundle and guiding
them dorsally into the contralateral hemisphere and away from the midline.
However, given the high degree of fasciculation and intermingling of axons
from each hemisphere that occurs within the callosal bundle
(Fig. 6B,C), the
possibility existed that postcrossing axons were effected by the aberrant
growth trajectories of precrossing axons and not directly by Slit2 and the
glial wedge. To investigate this, we devised a novel hemisected slice
preparation to specifically observe the growth of postcrossing callosal axons
(Fig. 7A). Slices of
living E17 brains were bisected at the midline and then cultured in collagen
gels. After fixation, DiI was injected into the callosal pathway to label
postcrossing axons that grew out of the slice and into the collagen gel that
was covering the slice. Postcrossing callosal axons could be specifically
analyzed in this assay and grew abundantly into the collagen when cultured
alone (n = 7; Fig.
6B,C). When explants of neocortex were placed in the path
of these axons (n = 7), postcrossing callosal axons grew into the
cortical explants (Fig.
6D,E). However, when explants of glial wedge were placed
in the pathway (n = 10), fewer axons grew out of the hemisected slice
(7 vs 20 axons, respectively; post hoc analysis with Newman-Keuls
test; p < 0.01; Fig.
7K), and very few entered the glial wedge (5 vs 0.7
axons, respectively; p < 0.01; Figs.
6F,G,
7J). To examine
whether this suppression-repulsion was caused, at least in part, by the
expression of Slit2, we added 20 ng/µl Robo1 and Robo2 ectodomain proteins
to the glial wedge-hemisected cortex cultures. In these cultures (n =
7), significantly more postcrossing callosal axons were now able to grow into
the glial wedge explants (7 vs 0.7 axons, respectively; p < 0.001)
and were longer in the presence of the Robo1/2 ectodomain proteins (210 µm
vs 110 µm; p < 0.001; Fig.
7L). Hence, the addition of Robo1 and Robo2 ectodomain
proteins was able to block the suppressive-repulsive effect of the glial
wedge.

View larger version (109K):
[in this window]
[in a new window]
|
Figure 7. The glial wedge supresses-repels the growth of postcrossing callosal axons
in vitro. To specifically study postcrossing callosal axons, we made
live coronal slices of E17 brains and bisected them along the midline to
obtain slices containing only one hemisphere. These hemisected slices were
grown in collagen for 3 d and then fixed and labeled with the cellular marker
Sytox green (green cellular labeling in all panels). Callosal axons were
visualized with DiI injected into the medial cortex of the slice
(A-I, red axons). A schematic of the slice culture is shown in
A. When slices were cultured alone, callosal axons crossed the
midline and grew into the collagen (B, C, arrow; C is a
higher-power view of the region delineated in B). Hemisected slices
cocultured with cortical explants (D, E; two different examples) had
callosal axons that grew into the collagen and entered the cortical explants
(D, E, arrows). However, when hemisected slices were cocultured with
glial wedge explants, fewer callosal axons left the slice and entered the
glial wedge (F, G; two different examples). In many cases, as the
callosal axons approached the glial wedge, they changed direction and turned
away (F, G, arrows). To investigate whether this
repulsive-suppressive effect on the growth of postcrossing callosal axons was
caused by Slit2, we added 20 ng/µl Robo1 and Robo2 ectodomain proteins to
the cultures. Two examples of these cultures are shown in H and
I, where callosal axons were now able to grow into the glial wedge
explant (H, I, arrows). Quantitation of these effects is shown in
J-L; the mean and SEM are shown. The number of axons entering the
explant is shown in J. The number and the length of axons that exited
the hemisected slice (regardless of whether they entered the opposing slice)
are shown in K and L, respectively. *p
< 0.01 (in J, K); *p < 0.001 (in
L). GW, Glial wedge explant; Ctx, cortex explant. Scale bar (in
I): B, 400 µm; C-I, 150 µm.
|
|
These data suggest that Slit2 and the glial wedge are required for the
correct axonal pathfinding of callosal axons on both sides of the midline.
 |
Discussion
|
|---|
Previous studies have suggested that Slit2 is required for precrossing
callosal axons to turn medially and cross the midline
(Shu and Richards, 2001
;
Bagri et al., 2002
). This
repulsion effectively inhibits callosal axons from entering the septum and
causes them to turn medially. What was unclear was whether callosal axons were
guided by the contralateral glial wedge after they crossed the midline. In the
mammalian spinal cord, commissural axons become responsive to Slit only after
they have crossed the midline (Zou et al.,
2000
). Slit, therefore, inhibits these axons from recrossing the
midline once they have crossed. The small size of the developing spinal cord
and the ventral location of the commissure make it difficult to ectopically
misexpress genes in this system in vivo without performing genomic
manipulations. Thus, the developing corpus callosum provides a more accessible
system to analyze gene function and commissure formation in vivo in
mammals through the use of techniques such as antisense oligonucleotides,
in utero injection of viral vectors, or in utero
electroporation. Furthermore, data provided here and elsewhere
(Erskine et al., 2000
;
Shu and Richards, 2001
;
Bagri et al., 2002
;
Hutson and Chien, 2002
;
Plump et al., 2002
) suggest
that the function of Slit2 at the midline of the brain may be different from
that of the spinal cord. In the brain, axons respond to Slit both before
crossing the midline as well as after they cross. One mechanism by which this
may occur is through the direct interaction of the Netrin-1 receptor deleted
in colorectal carcinoma (DCC) with Robo1/2. Recent evidence suggests that the
cytoplasmic domains of Robo1 and DCC can interact
(Stein and Tessier-Lavigne,
2001
) and that both receptors may operate together to mediate
repulsion in an UNC-6-Netrin-1-independent manner
(Yu et al., 2002
).
Becausecallosal axons express both Robo1/2 and DCC
(Shu et al., 2000
), these
receptors may operate together within this system to mediate repulsion on both
sides of the midline.
In vivo, postcrossing callosal axons displayed varying
morphologies in the Slit2 antisense oligonucleotide-injected brains. Some
axons deviated from the main bundle and grew down into the septum, whereas
others formed bundles of axons at the midline and did not enter the
contralateral hemisphere. These data suggest that in addition to keeping
callosal axons out of the septum as they cross the midline, Slit2 may be
required for axons to cross the midline and enter the contralateral
hemisphere. Given the mistargeting of axons on the same side as the antisense
oligonucleotide injections, it was reasonable to assume that the mistargeting
of contralateral axons may be caused by the fasciculation of these axons with
the aberrantly targeting ipsilateral axons. However, in vitro
analysis of postcrossing callosal axons independent of projections from the
contralateral hemisphere suggests that they still respond to the glial wedge
even after they cross the midline. This evidence does not exclude the
possibility that some of the postcrossing axons were led astray by
fasciculating with mistargeting axons from the ipsilateral hemisphere,
however, we did not observe this in our experiments.
Distinct differences exist in the way Slit2 regulates commissural
axon growth in the mammalian spinal cord and brain
In the mammalian spinal cord, Slit2 acts on commissural axons only after
they have crossed the midline (Zou et al.,
2000
), preventing them from recrossing the midline as they project
rostrally just lateral to the floorplate. In the developing visual system,
Slit1 and Slit2 act in concert on precrossing retinal ganglion cell (RGC)
axons, channeling them into the optic tract as they grow toward the chiasm
(Plump et al., 2002
). In
Slit1/2 double knock-out mice, many RGC axons cross aberrantly in ectopic
commissures anterior to the optic chiasm
(Plump et al., 2002
).
Furthermore, unlike the Drosophila nerve cord, Slit molecules do not
act to regulate ipsilateral versus contralateral axon crossing in the
mammalian visual system (Erskine et al.,
2000
; Plump et al.,
2002
). These data suggest that in the ventral forebrain Slits act
by channeling the axons within the tract and specifying where they cross the
midline. As in the visual system, Slit2 expressed by the glial wedge may
regulate the position of the midline callosal crossing point (in the
dorsal-ventral axis rather than the anterior-posterior axis). Given this model
and assuming that midline fusion had occurred more dorsally, it is possible
that ectopic expression of Slit2 more dorsally could force callosal axons to
cross more dorsally before their reaching the cortiocseptal boundary. However,
it is highly likely that additional molecules expressed within this region act
together with Slit2 to regulate callosal axon guidance. Evidence for this is
that, in Slit2 knockout mice, callosal axons initially penetrate the septum
but then form classic Probst bundles at the corticospetal boundary rather than
forming them more ventrally. Thus, additional molecules must be expressed that
prevent axons from remaining within the septal region.
Why is there a difference in Slit2 guidance between the brain and spinal
cord? It is probably because of morphological differences between the
structures present at the midline and, consequently, the expression of Slit2
at the midline. In the Drosophila nerve cord and the mammalian spinal
cord, midline glia and the floorplate respectively, provide a single source of
Slit2 expression, whereas the bilateral glial wedges of the cortical midline
provide two sources of Slit2. Furthermore, in the Drosophila nerve
cord and the mammalian spinal cord, axons remain in close proximity to the
midline after they cross and project rostrally or caudally. In the brain,
callosal axons leave the midline, growing away to enter the contralateral
hemisphere.
Slit molecules play a role in axon fasciculation in the mammalian
brain
In addition to their roles in axon repulsion, Slit1 and Slit2 have been
implicated in regulating axon fasciculation in the visual system
(Ringstedt et al., 2000
;
Plump et al., 2002
). In
Slit1/2 knock-out mice, RGC axons are defasciculated within the optic tract
and chiasm (Plump et al.,
2002
). Here, we also saw axon defasciculation occurring within the
callosal tract in Slit2 oligonucleotide-injected brains. Possible explanations
for this are that the defasciculation observed is a form of mild repulsion
that normally acts to "channel" the axons within the tract, or
that within the tract itself Slit2 promotes axon fasciculation through its
interaction with molecules of the extracellular matrix such as laminin
(Nguyen-Ba-Charvet et al.,
2001
) and heparan sulfate proteoglycans (Hu, 2001). Alternatively,
Slit may act differentially within the same commissural tract by repelling
some axons and causing the fasiculation of other axons. This could be mediated
through a variation in the concentration of Slit2 presented to different axons
(e.g., those on the outside might encounter a higher concentration than those
on the inside of the bundle) or by the expression of different Robo receptors
on the axons. In Drosophila, the expression of various combinations
of Robo receptors specifies whether longitudinally projecting axons will be
strongly or more weakly repulsed by a gradient of Slit
(Rajagopalan et al., 2000
;
Simpson et al., 2000
;
Goodhill, 2003
). There is
currently no evidence that the Robo receptors are differentially expressed on
axons within the callosal tract or that different axons within the tract
respond differently to Slit. Reagents necessary to study the protein
distribution of Slit and the Robo receptors are currently not available.
Thus, although there are many similarities in the way in which Slit and
Robo molecules function during development across species, even within the
same species, major differences in function exist, as described here, between
the mammalian spinal cord and brain.
 |
Footnotes
|
|---|
Received March 12, 2003;
revised July 18, 2003;
accepted July 21, 2003.
This work was supported by National Institutes of Health-National Institute
of Neurological Disorders and Stroke Grant NS37792 (L.J.R.). V.S. is a
recipient of a Medical Research Council (United Kingdom) Career Establishment
Award. We gratefully acknowledge the technical contributions of Kimberly M.
Valentino, Aika S. Mongi, and Adelaide Annan. We thank Drs. M. Tessier-Lavigne
and E. Stein for the gifts of Robo ectodomain expression plasmids.
Correspondence should be addressed to Dr. Linda J. Richards, Department of
Anatomy and Neurobiology, The University of Maryland, Baltimore, HSF 222, 685
West Baltimore Street, Baltimore, MD 21201. E-mail:
lrich001{at}umaryland.edu.
Copyright © 2003 Society for Neuroscience
0270-6474/03/238176-09$15.00/0
 |
References
|
|---|
Bagri A, Marin O, Plump AS, Mak J, Pleasure SJ, Rubenstein JLR,
Tessier-Lavigne M (2002) Slit proteins prevent midline crossing and determine
the dorsoventral position of major axonal pathways in the mammalian forebrain.
Neuron 33:233-248.
Brose K, Bland KS, Wang KH, Arnott D, Henzel W, Goodman CS,
Tessier-Lavigne M, Kidd T (1999) Slit proteins bind Robo receptors and have an
evolutionary conserved role in repulsive axon guidance. Cell
96:795-806.
Cummings DM, Malun D, Brunjes PC (1997) Development of the anterior
commissure in the opossum: midline extracellular space and glia coincide with
early axon decussation. J Neurobiol 32:403-414.
Erskine L, Williams SE, Brose K, Kidd T, Rachel RA, Goodman CS,
Tessier-Lavigne M, Mason CA (2000) Retinal ganglion cell axon guidance in the
mouse optic chiasm: expression and function of Robos and slits. J Neurosci
20:4975-4982.
Goodhill GJ (2003) A theoretical model of axon guidance by the Robo
code. Neural Comput 15:549-564.
Hivert B, Liu Z, Chuang CY, Doherty P, Sundaresan V (2002) Robo1
and robo2 are homophilic binding molecules that promote axonal growth. Mol
Cell Neurosci 21:534-545.
Hu H (1999) Chemorepulsion of neuronal migration by Slit2
in the developing mammalian forebrain. Neuron 23:703-711.
Hutson LD, Chien CB (2002) Pathfinding and error correction by
retinal axons: the role of astray/robo2. Neuron 33:205-217.
Jacobs JR, Goodman CS (1989) Embryonic development of axon pathways
in the Drosophila CNS. I. A glial scaffold appears before the first
growth cones. J Neurosci 9:2402-2411.
Kidd T, Brose K, Mitchell KJ, Fetter RD, Tessier-Lavigne M, Goodman
CS, Tear G (1998) Roundabout controls axon crossing of the CNS midline and
defines a novel subfamily of evolutionarily conserved guidance receptors. Cell
92:205-215.
Kidd T, Bland KS, Goodman CS (1999) Slit is the midline repellent
for the Robo receptor in Drosophila. Cell 96:785-794.
Li HS, Chen JH, Wu W, Fagaly T, Zhou L, Yuan W, Dupuis S, Jiang ZH,
Nash W, Gick C, Ornitz DM, Wu JY, Rao Y (1999) Vertebrate slit, a secreted
ligand for the transmembrane protein roundabout, is a repellent for olfactory
bulb axons. Cell 96:807-818.
Marcus RC, Blazeski R, Godement P, Mason CA (1995) Retinal axon
divergence in the optic chiasm: uncrossed axons diverge from crossed axons
within a midline glial specialization. J Neurosci 15:3716-3729.
Mori K, Ikeda J, Hayaishi O (1990) Monoclonal antibody R2D5 reveals
midsaggittal radial glial system in postnatally developing and adult
brainstem. Proc Natl Acad Sci USA 87:5489-5493.
Nguyen-Ba-Charvet KTN, Brose K, Marillat V, Kidd T, Goodman CS,
Tessier-Lavigne M, Sotelo C, Chedotal A (1999) Slit2-Mediated
chemorepulsion and collapse of developing forebrain axons. Neuron
22:463-473.
Nguyen-Ba-Charvet KT, Brose K, Marillat V, Sotelo C,
Tessier-Lavigne M, Chedotal A (2001) Sensory axon response to substrate-bound
Slit2 is modulated by laminin and cyclic GMP. Mol Cell Neurosci 17:1048
-1058.
Pires-Neto M, Braga-De-Souza S, Lent R (1998) Molecular tunnels and
boundaries for growing axons in the anterior commissure of hamster embryos. J
Comp Neurol 399:176-188.
Plump AS, Erskine L, Sabatier C, Brose K, Epstein CJ, Goodman CS,
Mason CA, Tessier-Lavigne M (2002) Slit1 and Slit2 cooperate to prevent
premature midline crossing of retinal axons in the mouse visual system. Neuron
33:219-232.
Polleux F, Giger RJ, Ginty DD, Kolodkin AL, Ghosh A (1998)
Patterning of cortical efferent projections by semaphorin-neuropilin
interactions. Science 282:1904-1906.
Rajagopalan S, Vivancos V, Nicolas E, Dickson BJ (2000) Selecting a
longitudinal pathway: Robo receptors specify the lateral position of axons in
the Drosophila CNS. Cell 103:1033-1045.
Rash BG, Richards LJ (2001) A role for cingulate pioneering axons
in the development of the corpus callosum. J Comp Neurol
434:147-157.
Richards LJ (2002) Axonal pathfinding mechanisms at the cortical
midline and in the development of the corpus callosum. Braz J Med Biol Res
35:1431-1439.
Ringstedt T, Braisted JE, Brose K, Kidd T, Goodman C,
Tessier-Lavigne M, O'Leary DDM (2000) Slit inhibition of retinal axon growth
and its role in retinal axon pathfinding and innervation patterns in the
diencephalon. J Neurosci 20:4983-4991.
Serafini T, Colamaino SA, Leonardo ED, Wang H, Beddington R,
Skarnes WC, Tessier-Lavigne M (1996) Netrin-1 is required for commissural axon
guidance in the developing vertebrate nervous system. Cell
87:1001-1014.
Shen Y, Mani S, Donovan SL, Schwob JE, Meiri KF (2002)
Growth-associated protein-43 is required for commissural axon guidance in the
developing vertebrate nervous system. J Neurosci 22:239-247.
Shu T, Richards LJ (2001) Cortical axon guidance by the glial wedge
during the development of the corpus callosum. J Neurosci 21:2749
-2758.
Shu T, Valentino KM, Seaman C, Cooper HM, Richards LJ (2000)
Expression of the netrin-1 receptor, deleted in colorectal cancer (DCC), is
largely confined to projecting neurons in the developing forebrain. J Comp
Neurol 416:201-212.
Shu T, Shen W-B, Richards LJ (2001) The development of projections
within the perforating pathway that intersects the corpus callosum. J Comp
Neurol 436:411-422.
Shu T, Butz KG, Plachez C, Gronostajski RM, Richards LJ (2003)
Abnormal development of forebrain midline glia and commissural projections in
Nfia knock-out mice. J Neurosci 23:203-212.
Simpson JH, Bland KS, Fetter RD, Goodman CS (2000) Short range and
long range guidance by Slit and its Robo receptors: a combinatorial code of
Robo receptors controls lateral position. Cell 103:1019-1032.
Snow DM, Steindler DA, Silver J (1990) Molecular and cellular
characterization of the glial roof plate of the spinal cord and optic tectum:
a possible role for a proteoglycan in the development of an axon barrier. Dev
Biol 38:359-376.
Stein E, Tessier-Lavigne M (2001) Hierarchical organization of
guidance receptors: silencing of netrin attraction by slit through a Robo/DCC
receptor complex. Science 291:1928-1938.
Szklarczyk A, Kaczmarek L (1995) Antisense
oligodeoxyribonucleotides: stability and distribution after intracerebral
injection into rat brain. J Neurosci Methods 60:181-187.
Toulme J (1997) Antisense oligodeoxynucleotides and antisense RNA.
In: Novel pharmacological and therapeutic agents (Weiss B, ed). New York:
CRC.
Van Hartesveldt C, Moore B, Hartman B (1986) Transient midline
raphe glial structure in the developing rat. J Comp Neurol
253:175-184.
Wang KH, Brose K, Arnott D, Kidd T, Goodman CS, Henzel W,
Tessier-Lavigne M (1999) Biochemical purification of a mammalian slit protein
as a positive regulator of sensory axon elongation and branching. Cell
96:771-784.
Wu DY, Schneider GE, Silver J, Poston M, Jhaveri S (1998) A role
for tectal midline glia in the unilateral containment of retinocollicular
axons. J Neurosci 18:8344-8355.
Yu TW, Hao JC, Lim W, Tessier-Lavigne M, Bargmann CI (2002) Shared
receptors in axon guidance: SAX3/Robo signals via UNC-34/Enabled and a
Netrin-independent UNC-40/DCC function. Nat Neurosci 5:1147-1154.
Zou Y, Stoeckli E, Chen H, Tessier-Lavigne M (2000) Squeezing axons
out of the gray matter: a role for slit and semaphorin proteins from midline
and ventral spinal cord. Cell 102:363-375.